News

News

1st February 2012 - The Robotic Drug Discovery Scientist: Cyclofluidic Announces First Fully Automated Lead Discovery Experiment

Cyclofluidic announces the completion of this key experiment triggering the release of milestone payments from investors UCB and Pfizer. Read our Press release here.

7th September 2011 - Cyclofluidic presents its hit to lead discovery platform at the ELRIG/SLAS/BPA Fifth Annual Drug Discovery Conference, 7 & 8 September 2011

visit our downloads page to view the presentation

9th February 2011 - Cyclofluidic announces its automated chemical synthesis-to-screen process for drug discovery

Read the press release here

16th October 2008 - Pfizer and UCB announce the formation of a new company "Cyclofluidic" to accelerate drug discovery process

read the press release here

Events

Cyclofluidic will be presenting at the forthcoming meetings:

SCI/RSC New Directions in Synthesis and Medicinal Chemistry, Biopark, Welwyn Garden City, 1st May 2012

Meet the team at the following meetings in 2012: please This e-mail address is being protected from spambots. You need JavaScript enabled to view it us to arrange a meeting

SLAS 2012, San Diego USA 4-8th February

Young and Emerging Healthcare Business - Delivering the Future, GSK Stevenage UK 1 March 2012

Academic Drug Discovery: Programmes and Collaborations, SCI London UK 1 March 2012

Discovery Chemistry Congress 2012, Munich Germany 13-14 March 2012

Bio-Europe Spring 2012, Amsterdam The Netherlands 19-21 March 2012

BioTrinity 2012, Newbury UK 24-26 April 2012

European Lab Automation, Hamburg Germany 30-31 May 2012

Normal 0 false false false EN-GB X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;}

PFIZER AND UCB ANNOUNCE FORMATION OF NEW COMPANY ‘CYCLOFLUIDIC’

TO ACCELERATE DRUG DISCOVERY PROCESS